[Chronic hepatitis C with early complication of Grave's disease during the treatment of pegylated interferon alpha-2a].

Maede, Yukiko; Morishita, Keiichi; Iwamura, Kunihiro; Takayama, Yukiko; Tsukada, Yuriko; Kishino, Maiko; Shimizu, Takeshi; Matsushima, Shouzou; Komatsu, Tatsuji; Kasagi, Youko

Maede, Yukiko; Morishita, Keiichi; Iwamura, Kunihiro; Takayama, Yukiko; Tsukada, Yuriko; Kishino, Maiko; Shimizu, Takeshi; Matsushima, Shouzou; Komatsu, Tatsuji; Kasagi, Youko.

Affiliation

Maede Y; Department of clinical research, National Hospital Organization Yokohama Medical Center, Yokohama.

Nihon Naika Gakkai Zasshi ; 94(12): 2600-2, 2005 Dec 10.

Article in Ja | MEDLINE | ID: mdl-16419601

Subject(s)

Antiviral Agents/adverse effects; Antiviral Agents/therapeutic use; Graves Disease/chemically induced; Hepatitis C, Chronic/drug therapy; Interferon-alpha/adverse effects; Polyethylene Glycols/adverse effects; Adult; Early Diagnosis; Female; Graves Disease/diagnosis; Graves Disease/drug therapy; Humans; Interferon alpha-2; Interferon-alpha/administration & dosage; Methimazole/therapeutic use; Polyethylene Glycols/administration & dosage; Recombinant Proteins; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Polyethylene Glycols / Graves Disease / Interferon-alpha / Hepatitis C, Chronic Type of study: Diagnostic_studies / Screening_studies Limits: Adult / Female / Humans Language: Ja Journal: Nihon Naika Gakkai Zasshi Year: 2005 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links